These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26561346)

  • 1. Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.
    Yaluri N; Modi S; López Rodríguez M; Stančáková A; Kuusisto J; Kokkola T; Laakso M
    PLoS One; 2015; 10(11):e0142902. PubMed ID: 26561346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells.
    Yada T; Nakata M; Shiraishi T; Kakei M
    Br J Pharmacol; 1999 Mar; 126(5):1205-13. PubMed ID: 10205010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.
    Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H
    J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of simvastatin on glucose metabolism in mouse MIN6 cells.
    Zhou J; Li W; Xie Q; Hou Y; Zhan S; Yang X; Xu X; Cai J; Huang Z
    J Diabetes Res; 2014; 2014():376570. PubMed ID: 24995341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
    Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
    Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
    Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
    Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
    Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S
    Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion.
    Kogure R; Toyama K; Hiyamuta S; Kojima I; Takeda S
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):58-63. PubMed ID: 22079287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niflumic acid-sensitive ion channels play an important role in the induction of glucose-stimulated insulin secretion by cyclic AMP in mice.
    Fujimoto W; Miki T; Ogura T; Zhang M; Seino Y; Satin LS; Nakaya H; Seino S
    Diabetologia; 2009 May; 52(5):863-72. PubMed ID: 19266181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing beta-cells.
    McQuaid TS; Saleh MC; Joseph JW; Gyulkhandanyan A; Manning-Fox JE; MacLellan JD; Wheeler MB; Chan CB
    J Endocrinol; 2006 Sep; 190(3):669-80. PubMed ID: 17003268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering of insulin release by a combination of cAMP signal and nutrients: an ATP-sensitive K+ channel-independent phenomenon.
    Komatsu M; Sato Y; Yamada S; Yamauchi K; Hashizume K; Aizawa T
    Diabetes; 2002 Feb; 51 Suppl 1():S29-32. PubMed ID: 11815454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway.
    Thams P; Anwar MR; Capito K
    Eur J Endocrinol; 2005 Apr; 152(4):671-7. PubMed ID: 15817925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP.
    Abdel-Halim SM; Guenifi A; Khan A; Larsson O; Berggren PO; Ostenson CG; Efendić S
    Diabetes; 1996 Jul; 45(7):934-40. PubMed ID: 8666145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin induces insulin resistance in L6 skeletal muscle myotubes by suppressing insulin signaling, GLUT4 expression and GSK-3β phosphorylation.
    Yaluri N; Modi S; Kokkola T
    Biochem Biophys Res Commun; 2016 Nov; 480(2):194-200. PubMed ID: 27743890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism.
    Kain V; Kapadia B; Misra P; Saxena U
    Sci Rep; 2015 Sep; 5():13823. PubMed ID: 26345110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
    Gromada J; Dissing S; Bokvist K; Renström E; Frøkjaer-Jensen J; Wulff BS; Rorsman P
    Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets.
    Yajima H; Komatsu M; Schermerhorn T; Aizawa T; Kaneko T; Nagai M; Sharp GW; Hashizume K
    Diabetes; 1999 May; 48(5):1006-12. PubMed ID: 10331404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.
    Arifin SA; Paternoster S; Carlessi R; Casari I; Ekberg JH; Maffucci T; Newsholme P; Rosenkilde MM; Falasca M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1132-1141. PubMed ID: 29883799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
    Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
    Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.